MiR-663a, regulated by lncRNA GAS5, contributes to osteosarcoma development through targeting MYL9
Authors:
- 7 July 2020
- journal article
- research article
- Published by SAGE Publications in Human & Experimental Toxicology
- Vol. 39 (12) , 1607-1618
Abstract
Osteosarcoma is characterized by high malignancy and high metastasis rate, resulting in high mortality and disability. MiR-663a has been reported in a variety of tumors to promote tumorigenesis. However, miR-663a has not been reported in the pathogenesis of osteosarcoma. Bioinformatics analysis and experiments including real-time quantitative polymerase chain reaction (RT-qPCR), luciferase reporter, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay, Western blot, RNA immunoprecipitation, and flow cytometry assay were applied to explore the function and mechanism of miR-663a in MG63, U2OS, Saos-2, SF-86, and hFOB1.19 cells. In this study, we found that miR-663a is highly expressed in osteosarcoma. At the same time, we discovered that miR-663a facilitates cell proliferation and migration, whereas suppresses cell apoptosis in osteosarcoma. Through a series of biological experiments, it was found that miR-663a regulates the cellular process in osteosarcoma by modulating the expression of MYL9. In addition, we also found that long noncoding RNA (lncRNA) GAS5 serves as a molecular sponge for miR-663a and regulates the progression of osteosarcoma via the ceRNA mechanism. We uncover that miR-663a promotes osteosarcoma development through targeting MYL9, which was regulated by lncRNA GAS5.Keywords
Funding Information
- Zhejiang Province Chinese Medicine Science and Technology Projection (2018ZB117)
This publication has 50 references indexed in Scilit:
- miR-215 promotes malignant progression of gastric cancer by targeting RUNX1Oncotarget, 2015
- MiR-125a suppresses tumor growth, invasion and metastasis in cervical cancer by targeting STAT3Oncotarget, 2015
- Bone microenvironment signals in osteosarcoma developmentCellular and Molecular Life Sciences, 2015
- Incidence, treatment and survival of paediatric patients with bone sarcomas in Finland from 1991 to 2005Acta Paediatrica, 2015
- Time-trends on incidence and survival in a nationwide and unselected cohort of patients with skeletal osteosarcomaActa Oncologica, 2014
- Histone methyltransferase SMYD3 promotes MRTF-A-mediated transactivation of MYL9 and migration of MCF-7 breast cancer cellsCancer Letters, 2014
- The Etiology of Osteosarcoma2009
- The Epidemiology of Osteosarcoma2009
- The Genetic Signatures of Noncoding RNAsPLOS Genetics, 2009
- Osteosarcoma incidence and survival rates from 1973 to 2004Cancer, 2009